证券代码：002001 证券简称：新和成 公告编号：2026-003 浙江新和成股份有限公司 关于第五期员工持股计划实施进展的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 浙江新和成股份有限公司（以下简称"公司"）于2025年12月10日召开第九 届董事会第十六次会议、第九届监事会第十一次会议，于2025年12月26日召开 2025年第三次临时股东大会，审议通过《浙江新和成股份有限公司第五期员工持 股计划（草案）及其摘要》等员工持股计划相关议案，同意公司实施第五期员工 持股计划。具体内容详见公司于2025年12月11日、2025年12月27日在指定信息披 露媒体及巨潮资讯网（http://www.cninfo.com.cn）上刊登的公告。 根据《关于上市公司实施员工持股计划试点的指导意见》《深圳证券交易所 上市公司自律监管指引第1号——主板上市公司规范运作》等相关规定，现将公 司第五期员工持股计划实施进展情况公告如下： 一、本员工持股计划的股票来源及数量 本员工持股计划将通过公司回购专用证券账户回购的公司股票和/或通过二 级市场购买（包括但不限于大宗交 ...

Core Insights - The report titled "2026-2032 China Feed Additives Industry Panorama Research and Market Analysis Forecast" provides a comprehensive overview of the feed additives industry, including market development environment, operational status, competitive landscape, key enterprise performance, and future trends and investment forecasts [2] Group 1: Industry Overview - The report introduces the definition, types, and basic functions of feed additives, highlighting their importance in animal nutrition [2] - It discusses the production processes of feed additives and factors leading to spoilage during feed processing [2] Group 2: Global Market Position and Forecast - China holds the position of the world's largest feed producer, with a significant focus on feed additives development in Asia [3] - The report predicts a continued emphasis on amino acids, vitamins, and enzyme preparations, alongside stricter regulations on drug feed additives [3][4] Group 3: Current Status and Trends in China - The Chinese feed additives industry is facing challenges such as high production costs and increased competition, leading to a concentration of resources and capital [4] - The report identifies a shift towards professionalized breeding, the development of unconventional feed resources, and a focus on low-carbon and environmentally friendly production methods [4] Group 4: Future Directions - Future trends in feed additives include the increased role of amino acids, the monopolization of vitamin production, and the widespread application of enzyme preparations [5][10] - The report emphasizes the need for innovation in green feed additives and the importance of addressing safety concerns related to feed additives [6][10] Group 5: Competitive Landscape - The competitive landscape of the global feed additives market is characterized by the presence of major animal nutrition companies, each with distinct development strategies [3] - The report highlights the necessity for companies to adapt to changing market dynamics and consumer preferences to maintain competitiveness [9]

截至2026年1月26日 13:16，中证医药及医疗器械创新指数(931484)成分股方面涨跌互现，华兰生物领涨 5.00%，英科医疗上涨2.54%，华润三九上涨1.16%；南微医学领跌。医疗创新ETF(516820)下跌最新报 价0.37元。 生物医药概念午后快速拉升，消息面上，1月下旬，印度西孟加拉邦突发尼帕病毒疫情，已造成多名医 护人员感染，泰国、尼泊尔紧急升级防控。 数据显示，截至2025年12月31日，中证医药及医疗器械创新指数(931484)前十大权重股分别为药明康 德、恒瑞医药、迈瑞医疗、爱尔眼科、片仔癀、新和成、华东医药、康龙化成、艾力斯、甘李药业，前 十大权重股合计占比63.75%。 从资金净流入方面来看，医疗创新ETF近6天获得连续资金净流入，最高单日获得4053.70万元净流入， 合计"吸金"8499.86万元，日均净流入达1416.64万元。（数据来源：Wind） 风险提示：基金有风险，投资需谨慎。基金管理人承诺以诚实信用、勤勉尽责的原则管理和运用基金资 产，但不保证本基金一定盈利，也不保证最低收益。基金管理人提醒投资人基金投资的"买者自负"原 则，在做出投资决策后，基金运营状况与基金 ...

Group 1 - The core viewpoint of the news highlights the performance of the medical innovation sector, with the China Securities Medical and Medical Device Innovation Index showing mixed results among its constituent stocks, led by Hualan Biological at a 0.90% increase [1] - The Medical Innovation ETF has seen continuous net inflows over the past six days, with a peak single-day net inflow of 40.54 million yuan, totaling 84.99 million yuan and an average daily net inflow of 14.17 million yuan [1] - Central China Television announced that Galaxy General Robotics will be the designated humanoid robot for the 2026 Spring Festival Gala, marking a significant milestone for the company established in May 2023, which focuses on a wide range of applications including retail, industrial, medical, and cultural tourism [1] Group 2 - The China Securities Medical and Medical Device Innovation Index consists of 30 publicly listed companies with strong profitability, growth potential, and research innovation capabilities, reflecting the overall performance of the medical and medical device sector [2] - As of December 31, 2025, the top ten weighted stocks in the index include WuXi AppTec, Hengrui Medicine, Mindray Medical, and others, collectively accounting for 63.75% of the index [2] Group 3 - The current medical device sector is at a turning point, with performance recovery expected in 2026, driven by new technologies such as AI in healthcare, brain-machine interfaces, and surgical robots, leading to a continuous revaluation of innovative products with global competitiveness [1]

Investment Rating - The industry investment rating is "Overweight," indicating an expected outperformance of the industry index relative to the benchmark by more than 5% over the next six months [67]. Core Insights - The report highlights significant price fluctuations in the chemical sector due to extreme weather conditions affecting natural gas prices in the U.S. [1]. - The average prices for various chemical products, including pure MDI, polymer MDI, and TDI, have shown a decline compared to the previous week, with respective price changes of -129, -114, and -213 CNY/ton [2]. - The report provides a detailed analysis of profit margins across different segments, indicating a decrease in margins for pure MDI and polymer MDI, while TDI margins remained relatively stable [2]. Summary by Sections 2.1 Basic Chemical Index Trends - The basic chemical index has shown a weekly increase of 7.3% as of January 23, 2026, with a year-to-date increase of 16.8% [8]. 2.2 Polyurethane Sector - The average prices for pure MDI, polymer MDI, and TDI are reported at 17,714, 13,900, and 13,975 CNY/ton respectively, with corresponding profit margins of 4,503, 1,689, and 2,459 CNY/ton [2][16]. 2.3 Oil, Coal, and Olefin Sector - Ethane and propane prices have increased by 210 and 21 CNY/ton respectively, while the average price for coal remains stable at 520 CNY/ton [2][22]. - The average price for polyethylene is reported at 7,100 CNY/ton, showing a slight decrease of 15 CNY/ton [2][28]. 2.4 Coal Chemical Sector - The average prices for synthetic ammonia, urea, DMF, and acetic acid are 2,211, 1,740, 3,894, and 2,600 CNY/ton respectively, with minor fluctuations in profit margins [2][41]. 2.5 Animal Nutrition Sector - The average prices for VA, VE, solid egg, and liquid egg are reported at 62.2, 54.5, 17.6, and 14.2 CNY/kg respectively, with minimal changes observed [2][54].

Investment Rating - The report maintains a strong rating for the chemical industry, indicating a positive outlook for the sector [5]. Core Insights - The chemical sector has shown resilience with the CITIC Basic Chemical Index rising by 5.73% and the Shenwan Chemical Index increasing by 7.29% this week [13][16]. - Key sub-industries such as soda ash, chlor-alkali, and dyeing chemicals have experienced significant price increases, with soda ash rising by 13.3% [16]. - The report highlights the competitive strength of domestic tire manufacturers and suggests focusing on companies like Sailun Tire and Linglong Tire as potential growth opportunities [4]. - The polyurethane project by Huide Technology, with an annual production capacity of 600,000 tons, has commenced, indicating strategic growth in the new materials sector [3]. - The report emphasizes the tightening supply-demand dynamics in the phosphate chemical sector due to environmental regulations and increasing demand from the new energy sector [4]. Summary by Sections Market Overview - The Shanghai Composite Index increased by 0.84%, while the ChiNext Index decreased by 0.34% [13]. - The overall performance of the chemical sector is positive, with notable gains in various sub-industries [16]. Key Sub-Industry Developments - **Polyurethane**: The price of pure MDI in East China is reported at 17,600 RMB/ton, showing a week-on-week decline of 1.12% [28]. - **Tires**: The operating load for all-steel tires in Shandong is at 62.70%, reflecting a year-on-year increase of 20.70% [49]. - **Fertilizers**: Urea prices are at 1,757.45 RMB/ton, with a week-on-week decrease of 0.4% [63]. - **Vitamins**: The price of Vitamin A is reported at 61.5 RMB/kg, down 1.6% week-on-week [79]. Investment Themes - **Tire Sector**: Domestic tire companies are positioned strongly, with a focus on growth stocks [4]. - **Consumer Electronics**: Recovery in demand is anticipated, benefiting upstream material companies [4]. - **Phosphate Chemicals**: Supply constraints due to environmental policies are expected to tighten the market [4]. - **Vitamin Supply**: Supply disruptions in Vitamin A and E are noted, creating potential investment opportunities [4].

Group 1 - The industry landscape is influenced by a combination of supply and demand factors [1] - The company aims to build a "Chemicals+" and "Biotechnology+" platform, continuously enriching its product line [1] - The company adopts a "technology + management + resources" model to enhance core competitiveness and improve operational performance [1] Group 2 - The company emphasizes a customer-centric and market-oriented sales strategy, providing innovative and efficient solutions to clients [1] - The company is focused on market expansion through various strategies, aiming to seize market opportunities and increase market share [1]

Group 1: Company Overview and Strategy - Zhejiang Xinhengcheng Co., Ltd. focuses on expanding its product lines and enhancing operational efficiency through innovation and cost control [2][3] - The company aims to leverage its "Chemical+" and "Biological+" strategies to capture growth opportunities in nutrition, new materials, and flavor industries [5][6] Group 2: Market Performance and Product Development - The market demand for methionine, a key amino acid, is expected to grow steadily due to global population increase and rising health awareness [3] - The company has completed the construction and debugging of a 70,000-ton methionine expansion project, which will be launched based on market conditions [3][4] Group 3: New Projects and Capacity Expansion - The nylon new materials project in Tianjin has commenced pile foundation construction, focusing on an integrated production chain for "adiponitrile-adipamide-nylon 66" [4] - The company plans to expand its production capacity for PPS (polyphenylene sulfide) and other materials, with current utilization rates at 100% [4][5] Group 4: Financial Performance and Shareholder Returns - In 2025, the company distributed a total cash dividend of 2.762 billion yuan, maintaining a dividend payout ratio of 30%-50% of net profits [6] - Cumulative cash dividends since listing have reached 16.1 billion yuan, reflecting the company's commitment to rewarding shareholders [6] Group 5: International Expansion and Market Reach - The company exports to over 100 countries, with international sales accounting for more than 50% of total revenue [5] - Overseas subsidiaries have been established in regions such as Hong Kong, Singapore, Germany, and Brazil to enhance market presence [5]

Core Insights - The commercial space industry is entering a golden era with significant developments from major players like SpaceX and Blue Origin, alongside China's aggressive satellite frequency resource claims [1][4][6] Group 1: SpaceX Developments - SpaceX plans to launch its second-generation Starlink satellite communication system in 2027, with an approved deployment of 7,500 new satellites, increasing overall capacity by over 100 times and data throughput by more than 20 times [1][2] - The acquisition of EchoStar's spectrum resources for $17 billion will enhance satellite connectivity to mobile phones, addressing spectrum bottlenecks [1][2] - The upgraded system will support video calls and HD streaming, breaking ground for high-speed internet access in remote areas [2][3] Group 2: Blue Origin's TeraWave - Blue Origin announced plans to deploy over 5,400 satellites by the end of 2027 to create the TeraWave communication network, offering symmetrical data transmission speeds of up to 6 Tbps [3][4] - The focus is on high-end markets, targeting government and large enterprises, providing flexible and stable global connectivity [3][4] - The technology features a multi-orbit optical interconnect architecture, enhancing network routing diversity and risk resilience [3][4] Group 3: China's Satellite Initiative - China has submitted a record application for frequency and orbital resources for 203,000 satellites, marking a significant strategic move in the global space communication landscape [4][5] - This initiative positions China to secure critical resources for the 6G era and marks a transition from following to leading in commercial space endeavors [4][5] - Plans are in place to deploy 13,000 low-orbit satellites between 2026 and 2030, with ongoing advancements in rocket technology and satellite manufacturing [5][6] Group 4: Industry Impact - The competition for orbital resources is intensifying, with SpaceX, Blue Origin, and China vying for dominance, making technological strength and first-mover advantage crucial [6][7] - The acceleration of technology iterations is evident, transitioning from basic communication to high-speed, specialized services [6][7] - The commercial landscape is opening up, with C-end markets benefiting from 5G-level satellite connectivity and B-end markets leveraging high-speed data for various applications [6][7] Group 5: Investment Opportunities - The entire supply chain, including satellite manufacturing, rocket launches, and ground equipment, is expected to benefit from increased demand, leading to technological breakthroughs and capacity expansions [7][8] - The market sentiment is buoyed by the announcements from major players, with commercial space stocks gaining traction and IPO processes accelerating for domestic companies [7][8] - The global landscape is shifting from single-nation dominance to a multi-player competition involving the US, China, and Europe, with China poised to play a significant role [7][8]

Core Viewpoint - The company has completed the construction and debugging of its 70,000-ton methionine expansion project and will release capacity based on market conditions [2] Group 1 - The 70,000-ton methionine expansion project is now ready for production [2] - The 180,000-ton per year (pure) liquid methionine project is operating smoothly after maintenance [2]